EGFR and Cortactin: Markers for potential double target therapy in oral squamous cell carcinoma.

MLA

Bissinger, Oliver, et al. “EGFR and Cortactin: Markers for Potential Double Target Therapy in Oral Squamous Cell Carcinoma.” Experimental & Therapeutic Medicine, vol. 14, no. 5, Nov. 2017, pp. 4620–26. EBSCOhost, https://doi.org/10.3892/etm.2017.5120.

APA

Bissinger, O., Kolk, A., Drecoll, E., Straub, M., Lutz, C., Wolff, K.-D., & Götz, C. (2017). EGFR and Cortactin: Markers for potential double target therapy in oral squamous cell carcinoma. Experimental & Therapeutic Medicine, 14(5), 4620–4626. https://doi.org/10.3892/etm.2017.5120

Chicago

Bissinger, Oliver, Andreas Kolk, Enken Drecoll, Melanie Straub, Christina Lutz, Klaus-Dietrich Wolff, and Carolin Götz. 2017. “EGFR and Cortactin: Markers for Potential Double Target Therapy in Oral Squamous Cell Carcinoma.” Experimental & Therapeutic Medicine 14 (5): 4620–26. doi:10.3892/etm.2017.5120.